Related Experiment Video
Updated: Feb 2, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
Endocrine disruptors of the bisphenol and paraben families and bone metabolism
J Vitku1, L Kolatorova, L Franekova
1Department of Steroids and Proteofactors, Institute of Endocrinology, Prague, Czech Republic. jvitku@endo.cz.
Abstract:
After menopause, when estrogen levels decrease, there is room for the activity of anthropogenic substances with estrogenic properties - endocrine disruptors (EDs) - that can interfere with bone remodeling and changes in calcium-phosphate metabolism. Selected unconjugated EDs of the bisphenol group - BPA, BPS, BPF, BPAF, and the paraben family - methyl-, ethyl-, propyl-, butyl-, and benzyl-parabens - were measured by high performance liquid chromatography-tandem mass spectrometry in the plasma of 24 postmenopausal women. Parameters of calcium-phosphate metabolism and bone mineral density were assessed. Osteoporosis was classified in 14 women, and 10 women were put into the control group. The impact of EDs on calcium-phosphate metabolism was evaluated by multiple linear regressions. In women with osteoporosis, concentrations of BPA ranged from the lower limit of quantification (LLOQ) - 104 pg/ml and methyl paraben (MP) from LLOQ - 1120 pg/ml. The alternative bisphenols BPS, BPF and BPAF were all under the LLOQ. Except for MP, no further parabens were detected in the majority of samples. The multiple linear regression model found a positive association of BPA (beta=0.07, p<0.05) on calcium (Ca) concentrations. Furthermore, MP (beta=-0.232, p<0.05) was negatively associated with C-terminal telopeptide. These preliminary results suggest that these EDs may have effects on calcium-phosphate metabolism.
Insights
Postmenopausal osteoporosis may be linked to endocrine disruptors (EDs). Bisphenol A (BPA) showed a positive association with calcium levels, while methylparaben (MP) negatively correlated with bone resorption markers.
Area of Science:
- Endocrinology
- Environmental Health
- Bone Metabolism
Background:
- Decreased estrogen post-menopause allows endocrine disruptors (EDs) to affect bone remodeling and calcium-phosphate metabolism.
- EDs are anthropogenic substances with estrogenic properties.
- Bisphenol (BPA, BPS, BPF, BPAF) and paraben families are common EDs.
Purpose of the Study:
- To measure specific EDs in postmenopausal women.
- To assess the impact of EDs on calcium-phosphate metabolism and bone mineral density.
- To investigate the relationship between EDs and osteoporosis in postmenopausal women.
Main Methods:
- High-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) measured unconjugated EDs in plasma.
- Calcium-phosphate metabolism and bone mineral density were assessed.
- Multiple linear regression analysis evaluated the impact of EDs on calcium-phosphate metabolism.
Main Results:
- Bisphenol A (BPA) and methylparaben (MP) were detected in postmenopausal women with osteoporosis.
- BPA showed a positive association with calcium (Ca) concentrations (beta=0.07, p<0.05).
- MP demonstrated a negative association with C-terminal telopeptide (beta=-0.232, p<0.05).
Conclusions:
- Preliminary findings suggest potential effects of BPA and MP on calcium-phosphate metabolism in postmenopausal women.
- EDs like BPA and MP may play a role in bone health changes after menopause.
- Further research is warranted to confirm these associations and elucidate mechanisms.
Related Concept Videos
Endocrine Signaling
Protein Families
Protein Families
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Gene Families
What is the Endocrine System?

